Patents by Inventor Radmila Micanovic

Radmila Micanovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protease resistant flint analogs
    Patent number: 6835814
    Abstract: The invention relates to FLINT analogs that are to proteolysis in vivo and in vitro at amino acid position 218 of mature FLINT, clinical and therapeutic uses thereof, and pharmaceutical formulations comprising said analogs.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: December 28, 2004
    Assignee: Eli Lilly and Company
    Inventors: Radmila Micanovic, Radhakrishnan Rathnachalam, Derrick Ryan Witcher
  • GLP-1 Fusion Proteins
    Publication number: 20040053370
    Abstract: The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
    Type: Application
    Filed: May 29, 2003
    Publication date: March 18, 2004
    Inventors: Wolfgang Glaesner, Radmila Micanovic, Sheng-Hung Rainbow Tschang
  • Novel secreted proteins and their uses
    Publication number: 20040038242
    Abstract: The present invention provides nucleic acid sequences encoding novel human proteins. These novel nucleic acids are useful for constructing the claimed DNA vectors and host cells of the invention and for preparing the claimed nucleic acids, recombinant proteins and antibodies that are useful in the claimed methods and medical uses.
    Type: Application
    Filed: January 29, 2003
    Publication date: February 26, 2004
    Inventors: Brian Taylor Edmonds, Radmila Micanovic, Weijia Ou, Eric Wen Su, Sheng-Hung Rainbow Tschang, He Wang